Protara Therapeutics, Inc. (TARA)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
20-Jan-23 4:00 PM
View: 
Shefferman Jesse
CEO and President
Director
Protara Therapeutics, Inc. (TARA) 19-Jan-23Grant 51,300----6%
866.98K to 918.28K
20-Jan-23 4:00 PM
View: 
Zummo Jacqueline
Chf Scientific Operations Off
Protara Therapeutics, Inc. (TARA) 19-Jan-23Grant 19,900----28%
71.57K to 91.47K
20-Jan-23 4:00 PM
View: 
Bandari Jathin
Chief Medical Officer
Protara Therapeutics, Inc. (TARA) 19-Jan-23Grant 20,700----112%
18.44K to 39.14K
20-Jan-23 4:00 PM
View: 
Fry Hannah
VP, Controller
Protara Therapeutics, Inc. (TARA) 19-Jan-23Grant 5,900----22%
27.24K to 33.14K
11-Jan-23 4:03 PM
View: 
Shefferman Jesse
CEO and President
Director
Protara Therapeutics, Inc. (TARA) 10-Jan-23Payment of Exercise 5,855$3.00$17,565.00(< 1%)
872.84K to 866.98K
11-Jan-23 4:05 PM
View: 
Zummo Jacqueline
Chf Scientific Operations Off
Protara Therapeutics, Inc. (TARA) 10-Jan-23Payment of Exercise 5,225$3.00$15,675.00(7%)
76.8K to 71.57K
11-Jan-23 4:02 PM
View: 
Bandari Jathin
Chief Medical Officer
Protara Therapeutics, Inc. (TARA) 10-Jan-23Payment of Exercise 1,876$3.00$5,628.00(9%)
20.32K to 18.44K
04-Jan-23 4:25 PM
View: 
Shefferman Jesse
CEO and President
Director
Protara Therapeutics, Inc. (TARA) 03-Jan-23Payment of Exercise 6,604$2.80$18,491.20(< 1%)
879.44K to 872.84K
04-Jan-23 4:26 PM
View: 
Zummo Jacqueline
Chf Scientific Operations Off
Protara Therapeutics, Inc. (TARA) 03-Jan-23Payment of Exercise 2,159$2.80$6,045.20(3%)
78.96K to 76.8K
04-Jan-23 4:24 PM
View: 
Fry Hannah
VP, Controller
Protara Therapeutics, Inc. (TARA) 03-Jan-23Payment of Exercise 361$2.80$1,010.80(1%)
27.6K to 27.24K
30-Dec-22 6:00 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 30-Dec-22Private Sale 15,473$2.71$41,948.90< 1%
2.68M to 2.69M
15-Sep-22 4:05 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 15-Sep-22Purchase 7,300$3.80$27,740.00< 1%
2.7M to 2.71M
15-Sep-22 4:05 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 14-Sep-22Private Purchase 16,600$3.98$66,068.00< 1%
2.68M to 2.7M
15-Aug-22 5:49 PM
View: 
Shefferman Jesse
CEO and President
Director
Protara Therapeutics, Inc. (TARA) 11-Aug-22Private Purchase 9,065$3.84$34,809.601%
870.38K to 879.44K
19-Jul-22 4:06 PM
View: 
Fry Hannah
VP, Controller
Protara Therapeutics, Inc. (TARA) 16-Jul-22Grant 25,000----962%
2.6K to 27.6K
19-Jul-22 4:31 PM
View: 
Davis Blaine
Chief Financial Officer
Protara Therapeutics, Inc. (TARA) 15-Jul-22Payment of Exercise 5,081$3.13$15,903.50(20%)
25.74K to 20.66K
05-Jul-22 5:00 PM
View: 
Bandari Jathin
Chief Medical Officer
Protara Therapeutics, Inc. (TARA) 01-Jul-22Payment of Exercise 682$3.22$2,196.04(3%)
21.0K to 20.32K
05-Jul-22 5:00 PM
View: 
Beshar Luke M
Director
Protara Therapeutics, Inc. (TARA) 30-Jun-22Private Purchase 10,000$3.10$31,000.005%
188.0K to 198.0K
08-Apr-22 6:45 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 08-Apr-22Purchase 7,791$4.80$37,364.10< 1%
2.55M to 2.56M
08-Apr-22 6:45 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 07-Apr-22Private Purchase 2,345$4.74$11,122.80< 1%
2.67M to 2.68M
16-Mar-22 4:37 PM
View: 
Beshar Luke M
Director
Protara Therapeutics, Inc. (TARA) 14-Mar-22Private Purchase 10,000$4.25$42,500.006%
178.0K to 188.0K
14-Mar-22 4:37 PM
View: 
Beshar Luke M
Director
Protara Therapeutics, Inc. (TARA) 10-Mar-22Private Purchase 10,000$4.46$44,555.006%
168.0K to 178.0K
31-Jan-22 4:05 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 28-Jan-22Private Purchase 24,031$4.96$119,271.00< 1%
2.65M to 2.67M
12-Jan-22 5:20 PM
View: 
Zummo Jacqueline
Chf Scientific Operations Off
Protara Therapeutics, Inc. (TARA) 10-Jan-22Payment of Exercise 4,603$6.27$28,860.80(6%)
83.56K to 78.96K
0%
12-Jan-22 5:18 PM
View: 
Shefferman Jesse
CEO and President
Director
Protara Therapeutics, Inc. (TARA) 10-Jan-22Payment of Exercise 5,080$6.27$31,851.60(< 1%)
877.5K to 872.42K
0%
12-Jan-22 5:16 PM
View: 
Bandari Jathin
Chief Medical Officer
Protara Therapeutics, Inc. (TARA) 10-Jan-22Grant 13,500----100%
0 to 13.5K
05-Jan-22 4:35 PM
View: 
Davis Blaine
Chief Financial Officer
Protara Therapeutics, Inc. (TARA) 03-Jan-22Grant 14,100----952%
1.48K to 15.58K
05-Jan-22 4:36 PM
View: 
Shefferman Jesse
CEO and President
Director
Protara Therapeutics, Inc. (TARA) 03-Jan-22Grant 42,300----5%
835.21K to 877.5K
05-Jan-22 4:37 PM
View: 
Zummo Jacqueline
Chf Scientific Operations Off
Protara Therapeutics, Inc. (TARA) 03-Jan-22Grant 14,100----20%
69.46K to 83.56K
29-Dec-21 7:36 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 29-Dec-21Market Purchase 4,500$6.98$31,407.80< 1%
2.65M to 2.65M
(9%)
29-Dec-21 7:36 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 28-Dec-21Market Purchase 7,091$6.36$45,090.20< 1%
2.64M to 2.65M
< 1%
27-Dec-21 6:52 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 27-Dec-21Market Purchase 36,700$6.53$239,713.001%
2.6M to 2.64M
27-Dec-21 6:52 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 23-Dec-21Market Purchase 1,300$6.60$8,580.00< 1%
2.6M to 2.6M
5%
22-Dec-21 4:05 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 20-Dec-21Market Purchase 703$6.49$4,562.47< 1%
2.5M to 2.5M
4%
20-Dec-21 4:00 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 17-Dec-21Market Purchase 2,790$6.60$18,414.00< 1%
2.6M to 2.6M
1%
20-Dec-21 4:00 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 16-Dec-21Market Purchase 7,563$6.41$48,484.90< 1%
2.59M to 2.6M
4%
19-Nov-21 4:10 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 18-Nov-21Market Purchase 15,206$6.98$106,130.00< 1%
2.57M to 2.59M
< 1%
19-Nov-21 4:10 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 17-Nov-21Market Purchase 9,118$6.98$63,643.60< 1%
2.57M to 2.57M
< 1%
08-Nov-21 2:30 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 04-Nov-21Private Purchase 6,557$6.50$42,620.50< 1%
2.56M to 2.57M
14-Jun-21 5:52 PM
View: 
Olivo Martin Sebastian
Chief Medical Officer
Protara Therapeutics, Inc. (TARA) 10-Jun-21Market Purchase 9,893$10.10$99,968.10222%
4.45K to 14.34K
(1%)
13-Jan-21 5:19 PM
View: 
Zummo Jacqueline
Chf Scientific Operations Off
Protara Therapeutics, Inc. (TARA) 11-Jan-21Payment of Exercise 4,653$21.16$98,457.50(6%)
74.11K to 69.46K
56%
13-Jan-21 5:16 PM
View: 
Shefferman Jesse
CEO and President
Director
Protara Therapeutics, Inc. (TARA) 11-Jan-21Payment of Exercise 5,069$21.16$107,260.00(< 1%)
840.27K to 835.21K
56%
02-Oct-20 6:05 AM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 30-Sep-20Market Purchase 50,000$16.00$800,000.002%
2.51M to 2.56M
(46%)
25-Sep-20 5:15 PM
View: 
Opaleye Management Inc.
10% Owner
Protara Therapeutics, Inc. (TARA) 24-Sep-20Market Purchase 300,000$16.87$5,061,000.0014%
2.21M to 2.51M
(49%)
23-Sep-20 9:20 AM
View: 
Davis Blaine
Chief Financial Officer
Protara Therapeutics, Inc. (TARA) 22-Sep-20Market Purchase 1,481$16.91$25,037.80100%
0 to 1.48K
(49%)
15-Sep-20 6:04 PM
View: 
Marshall Randall
Protara Therapeutics, Inc. (TARA) 14-Sep-20Market Sale 2,554$19.40$49,540.80(< 1%)
588.15K to 585.6K
56%
14-Sep-20 4:37 PM
View: 
Marshall Randall
10% Owner
Protara Therapeutics, Inc. (TARA) 10-Sep-20Market Sale 239$18.00$4,302.00(< 1%)
588.39K to 588.15K
52%
10-Sep-20 3:58 PM
View: 
Marshall Randall
10% Owner
Protara Therapeutics, Inc. (TARA) 09-Sep-20Market Sale 10,222$18.66$190,766.00(2%)
598.62K to 588.39K
54%
10-Sep-20 3:58 PM
View: 
Marshall Randall
10% Owner
Protara Therapeutics, Inc. (TARA) 08-Sep-20Market Sale 3,108$18.94$58,865.50(< 1%)
601.72K to 598.62K
55%
04-Sep-20 4:39 PM
View: 
Marshall Randall
10% Owner
Protara Therapeutics, Inc. (TARA) 03-Sep-20Market Sale 52$20.19$1,049.88(< 1%)
601.77K to 601.72K
57%